» Articles » PMID: 32989410

Leveraging Computational Modeling to Understand Infectious Diseases

Overview
Specialty Pathology
Date 2020 Sep 29
PMID 32989410
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Computational and mathematical modeling have become a critical part of understanding in-host infectious disease dynamics and predicting effective treatments. In this review, we discuss recent findings pertaining to the biological mechanisms underlying infectious diseases, including etiology, pathogenesis, and the cellular interactions with infectious agents. We present advances in modeling techniques that have led to fundamental disease discoveries and impacted clinical translation.

Recent Findings: Combining mechanistic models and machine learning algorithms has led to improvements in the treatment of and tuberculosis through the development of novel compounds. Modeling of the epidemic dynamics of malaria at the within-host and between-host level has afforded the development of more effective vaccination and antimalarial therapies. Similarly, in-host and host-host models have supported the development of new HIV treatment modalities and an improved understanding of the immune involvement in influenza. In addition, large-scale transmission models of SARS-CoV-2 have furthered the understanding of coronavirus disease and allowed for rapid policy implementations on travel restrictions and contract tracing apps.

Summary: Computational modeling is now more than ever at the forefront of infectious disease research due to the COVID-19 pandemic. This review highlights how infectious diseases can be better understood by connecting scientists from medicine and molecular biology with those in computer science and applied mathematics.

Citing Articles

Bioinformatics and molecular biology tools for diagnosis, prevention, treatment and prognosis of COVID-19.

Meira D, Zetum A, Casotti M, Campos da Silva D, de Araujo B, Vicente C Heliyon. 2025; 10(14):e34393.

PMID: 39816364 PMC: 11734128. DOI: 10.1016/j.heliyon.2024.e34393.


Digital Twins of Biological Systems: A Narrative Review.

Alsalloum G, Al Sawaftah N, Percival K, Husseini G IEEE Open J Eng Med Biol. 2024; 5:670-677.

PMID: 39184962 PMC: 11342927. DOI: 10.1109/OJEMB.2024.3426916.


NIAID/SMB Workshop on Multiscale Modeling of Infectious and Immune-Mediated Diseases.

Shabman R, Craig M, Laubenbacher R, Reeves D, Brown L Bull Math Biol. 2024; 86(5):44.

PMID: 38512541 PMC: 10957590. DOI: 10.1007/s11538-024-01276-2.


Determining the rate of infectious disease testing through contagion potential.

Roy S, Biswas P, Ghosh P PLOS Glob Public Health. 2023; 3(8):e0002229.

PMID: 37531354 PMC: 10395932. DOI: 10.1371/journal.pgph.0002229.


Natural Products as a Potential Source of Promising Therapeutics for COVID-19 and Viral Diseases.

Bafandeh S, Khodadadi E, Ganbarov K, Asgharzadeh M, Kose S, Kafil H Evid Based Complement Alternat Med. 2023; 2023:5525165.

PMID: 37096202 PMC: 10122587. DOI: 10.1155/2023/5525165.


References
1.
Simoni J, Pearson C, Pantalone D, Marks G, Crepaz N . Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006; 43 Suppl 1:S23-35. PMC: 4044045. DOI: 10.1097/01.qai.0000248342.05438.52. View

2.
Wei X, Ghosh S, Taylor M, Johnson V, Emini E, Deutsch P . Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995; 373(6510):117-22. DOI: 10.1038/373117a0. View

3.
Davis C, Wahid R, Toapanta F, Simon J, Sztein M, Levy D . Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics. PLoS One. 2013; 8(4):e59465. PMC: 3614931. DOI: 10.1371/journal.pone.0059465. View

4.
Germain R, Meier-Schellersheim M, Nita-Lazar A, Fraser I . Systems biology in immunology: a computational modeling perspective. Annu Rev Immunol. 2011; 29:527-85. PMC: 3164774. DOI: 10.1146/annurev-immunol-030409-101317. View

5.
Perelson A, Ribeiro R . Introduction to modeling viral infections and immunity. Immunol Rev. 2018; 285(1):5-8. PMC: 6312192. DOI: 10.1111/imr.12700. View